The controlling shareholder of Star Lake Bioscience (600866.SH) has completed the increase in holding of the company's 0.68% stake.
Star Lake Technology (600866.SH) has announced that its controlling shareholder, Guangdong Guangxin Holdings Group Co., Ltd. (abbreviated as...)
Star Lake Bioscience (600866.SH) announced that the controlling shareholder Guangdong Guangxin Holding Group Co., Ltd. (referred to as "Guangxin Group") has completed the implementation of its share increase plan. Guangxin Group has acquired a total of 11.3018 million shares of the company through centralized competitive bidding on the Shanghai Stock Exchange, representing 0.68% of the total share capital of the company. The total amount of the share increase is RMB 51.2965 million. This share increase plan has been completed.
Related Articles
HK Stock Market Move | TSINGTAO BREW(00168) falls nearly 3% as industry peak-season growth misses expectations; Citi cuts the company's sales forecasts for this year and next
Market questions the outlook, yet Goldman Sachs Group, Inc. remains actively pricing Netflix's (NFLX.US) "hit IP + advertising monetization" growth narrative: price target points to 30% upside.
New Stock News | NEEQ smart passenger transport operator Zhongyun Technology plans to list in Hong Kong.
HK Stock Market Move | TSINGTAO BREW(00168) falls nearly 3% as industry peak-season growth misses expectations; Citi cuts the company's sales forecasts for this year and next
Market questions the outlook, yet Goldman Sachs Group, Inc. remains actively pricing Netflix's (NFLX.US) "hit IP + advertising monetization" growth narrative: price target points to 30% upside.
New Stock News | NEEQ smart passenger transport operator Zhongyun Technology plans to list in Hong Kong.
